Abstract
The purpose of this study was to investigate the cognitive and behavioral effects of anticholinergic, antidopaminergic, and antiserotonergic agents given alone and in combination to normal volunteers. Twelve young male volunteers took part in this double-blind, randomized, placebo-controlled, crossover study of six drug conditions, each administered on separate days [haloperidol (2 mg PO) ± scopolamine (0.5 mg IV), metergoline (4 mg PO) ± scopolamine (0.5 mg IV), placebo, and scopolamine alone (0.5 mg IV)]. Scopolamine-induced sedation (p <. 01), slowed information processing (p <. 01) and impaired new learning and memory (p <. 01), but did not affect attention or retrieval from semantic memory. Given alone, haloperidol selectively impaired the ability to rapidly switch cognitive sets (p <. 05), and metergoline decreased pupil size (p <. 01) but did not induce cognitive deficits. In combination with scopolamine, neither haloperidol nor metergoline produced a worsening of the subjects′ cognitive performance above and beyond that seen with scopolamine alone. On the contrary, a trend (p <. 10) for haloperidol to reverse some of the scopolamine-induced exacerbation of verbal short-term forgetting was observed. The data indicate that scopolamine and haloperidol can independently and selectively affect cognition and that at the doses tested in this study no synergistic exacerbation of cognitive functioning was found when cholinergic blockage was coupled with dopaminergic or serotonergic blockade.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
A previous version of this report was presented at the 30th annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1991.
Rights and permissions
About this article
Cite this article
Vitiello, B., Martin, A., Hill, J. et al. Cognitive and Behavioral Effects of Cholinergic, Dopaminergic, and Serotonergic Blockade in Humans. Neuropsychopharmacol 16, 15–24 (1997). https://doi.org/10.1016/S0893-133X(96)00134-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(96)00134-0
Keywords
This article is cited by
-
Dynamic modulation of inequality aversion in human interpersonal negotiations
Communications Biology (2022)
-
Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study
Journal of Cancer Survivorship (2019)
-
Mechanisms of Cognitive Aging in the HIV-Positive Adult
Current Behavioral Neuroscience Reports (2017)
-
Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats
Acta Pharmacologica Sinica (2013)
-
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Neuropsychopharmacology (2012)